VS

Venkata Sivarama Krishna Palanki

Active Director Director DIN 10552933
DIN 10552933 First appointment Mar 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Venkata Sivarama Krishna Palanki

Data last updated:

Venkata Sivarama Krishna Palanki is a Director at Prosam Lifesciences Private Limited (since 2024). The company operates in Pharma.

DIN 10552933
Primary Designation Director
Industry Pharma
First Appointment 16 Mar 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Prosam Lifesciences Private Limited U47720TS2024PTC183467
Director16 Mar 20242024Active

Board colleagues of Venkata Sivarama Krishna Palanki

Directorship timeline

Open interactive timeline →
Prosam Lifesciences Private Limited
Premium access

Shareholding and investment profile for Venkata Sivarama Krishna Palanki

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Venkata Sivarama Krishna Palanki

Venkata Sivarama Krishna Palanki currently holds 1 directorship: Prosam Lifesciences Private Limited (Director, since 16 Mar 2024).

Venkata Sivarama Krishna Palanki was first appointed on 16 Mar 2024 as Director at Prosam Lifesciences Private Limited.

The current boards of Venkata Sivarama Krishna Palanki's companies include Mothukuri Swetha (Prosam Lifesciences Private Limited), Putty Krishnamoorthy Jaishree (Prosam Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available